These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 22982733

  • 1. A novel dry powder inhalable formulation incorporating three first-line anti-tubercular antibiotics.
    Chan JG, Chan HK, Prestidge CA, Denman JA, Young PM, Traini D.
    Eur J Pharm Biopharm; 2013 Feb; 83(2):285-92. PubMed ID: 22982733
    [Abstract] [Full Text] [Related]

  • 2. Bedaquiline containing triple combination powder for inhalation to treat drug-resistant tuberculosis.
    Rangnekar B, Momin MAM, Eedara BB, Sinha S, Das SC.
    Int J Pharm; 2019 Oct 30; 570():118689. PubMed ID: 31513868
    [Abstract] [Full Text] [Related]

  • 3. L-Leucine as an excipient against moisture on in vitro aerosolization performances of highly hygroscopic spray-dried powders.
    Li L, Sun S, Parumasivam T, Denman JA, Gengenbach T, Tang P, Mao S, Chan HK.
    Eur J Pharm Biopharm; 2016 May 30; 102():132-41. PubMed ID: 26970252
    [Abstract] [Full Text] [Related]

  • 4. Phospholipid-based pyrazinamide spray-dried inhalable powders for treating tuberculosis.
    Eedara BB, Tucker IG, Das SC.
    Int J Pharm; 2016 Jun 15; 506(1-2):174-83. PubMed ID: 27091294
    [Abstract] [Full Text] [Related]

  • 5. Protection of hydrophobic amino acids against moisture-induced deterioration in the aerosolization performance of highly hygroscopic spray-dried powders.
    Yu J, Chan HK, Gengenbach T, Denman JA.
    Eur J Pharm Biopharm; 2017 Oct 15; 119():224-234. PubMed ID: 28655664
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Investigations on the Mechanism of Magnesium Stearate to Modify Aerosol Performance in Dry Powder Inhaled Formulations.
    Jetzer MW, Schneider M, Morrical BD, Imanidis G.
    J Pharm Sci; 2018 Apr 15; 107(4):984-998. PubMed ID: 29247741
    [Abstract] [Full Text] [Related]

  • 9. Colistin powders with high aerosolisation efficiency for respiratory infection: preparation and in vitro evaluation.
    Zhou QT, Morton DA, Yu HH, Jacob J, Wang J, Li J, Chan HK.
    J Pharm Sci; 2013 Oct 15; 102(10):3736-47. PubMed ID: 23904207
    [Abstract] [Full Text] [Related]

  • 10. Tuning aerosol performance using the multibreath Orbital® dry powder inhaler device: controlling delivery parameters and aerosol performance via modification of puck orifice geometry.
    Zhu B, Young PM, Ong HX, Crapper J, Flodin C, Qiao EL, Phillips G, Traini D.
    J Pharm Sci; 2015 Jul 15; 104(7):2169-76. PubMed ID: 25931324
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Investigation of the Changes in Aerosolization Behavior Between the Jet-Milled and Spray-Dried Colistin Powders Through Surface Energy Characterization.
    Jong T, Li J, Morton DA, Zhou QT, Larson I.
    J Pharm Sci; 2016 Mar 15; 105(3):1156-63. PubMed ID: 26886330
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Powder, capsule and device: An imperative ménage à trois for respirable dry powders.
    Schoubben A, Blasi P, Giontella A, Giovagnoli S, Ricci M.
    Int J Pharm; 2015 Oct 15; 494(1):40-8. PubMed ID: 26255220
    [Abstract] [Full Text] [Related]

  • 16. Triple combination dry powder formulation of pretomanid, moxifloxacin, and pyrazinamide for treatment of multidrug-resistant tuberculosis.
    Fan C, Eedara BB, Sinha S, Uddin MKM, Doyle C, Banu S, Das SC.
    Int J Pharm; 2024 Apr 10; 654():123984. PubMed ID: 38461874
    [Abstract] [Full Text] [Related]

  • 17. Carrier-free combination dry powder inhaler formulation of ethionamide and moxifloxacin for treating drug-resistant tuberculosis.
    Momin MAM, Sinha S, Tucker IG, Das SC.
    Drug Dev Ind Pharm; 2019 Aug 10; 45(8):1321-1331. PubMed ID: 31014129
    [Abstract] [Full Text] [Related]

  • 18. Capreomycin inhalable powders prepared with an innovative spray-drying technique.
    Schoubben A, Giovagnoli S, Tiralti MC, Blasi P, Ricci M.
    Int J Pharm; 2014 Jul 20; 469(1):132-9. PubMed ID: 24747443
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of highly branched cyclic dextrin in inhalable particles of combined antibiotics for the pulmonary delivery of anti-tuberculosis drugs.
    Kadota K, Senda A, Tagishi H, Ayorinde JO, Tozuka Y.
    Int J Pharm; 2017 Jan 30; 517(1-2):8-18. PubMed ID: 27913241
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.